Caspofungin as treatment for Candida glabrata hip infection

被引：25
|
作者：
Lejko-Zupanc, T
Mozina, E
Vrevc, F
机构：
[1] Med Ctr Ljubljana, Dept Infect Dis, Ljubljana 1000, Slovenia
[2] Med Ctr Ljubljana, Inst Radiol, Ljubljana 1000, Slovenia
[3] Med Ctr Ljubljana, Dept Orthopaed Surg, Ljubljana 1000, Slovenia
来源：
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS | 2005年 / 25卷 / 03期
关键词：
D O I：
10.1016/j.ijantimicag.2005.01.005
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
引用
收藏
页码：273 / 274
页数：2
相关论文
共 50 条
  • [31] Identification of Candida glabrata mutants with altered sensitivity to caspofungin, a β-glucan synthase inhibitor
    Rosenwald, A.
    Arora, G. S.
    Ferrandino, R. M.
    Gerace, E. L.
    Mohammednetej, M.
    Nosair, W.
    Rattila, S.
    Zirzow, A. C.
    Rolfes, R. J.
    MOLECULAR BIOLOGY OF THE CELL, 2015, 26
  • [32] Posaconazole activity against Candida glabrata after exposure to caspofungin or amphotericin B
    Spreghini, Elisabetta
    Maida, Carmelo Massimo
    Milici, Maria Eleonora
    Scalise, Giorgio
    Barchiesi, Francesco
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2008, 52 (02) : 513 - 517
  • [33] Caspofungin MICs Correlate with Treatment Outcomes among Patients with Candida glabrata Invasive Candidiasis and Prior Echinocandin Exposure
    Shields, Ryan K.
    Nguyen, M. Hong
    Press, Ellen G.
    Updike, Cassaundra L.
    Clancy, Cornelius J.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2013, 57 (08) : 3528 - 3535
  • [34] Detailed comparison of Candida albicans and Candida glabrata biofilms under different conditions and their susceptibility to caspofungin and anidulafungin
    Kucharikova, Sona
    Tournu, Helene
    Lagrou, Katrien
    Van Dijck, Patrick
    Bujdakova, Helena
    JOURNAL OF MEDICAL MICROBIOLOGY, 2011, 60 (09) : 1261 - 1269
  • [35] Candida krusei -: a serious infection in patients with hernatological malignancies:: successful treatment with Caspofungin
    Conen, A.
    Weisser, M.
    Joerg, C. Orasch
    Battegay, M.
    Trampuz, A.
    Frei, R.
    Christen, S.
    Heim, D.
    Gratwohl, A.
    Flueckiger, U.
    SWISS MEDICAL WEEKLY, 2007, 137 : 49S - 49S
  • [36] Successful treatment of Candida krusei infection with caspofungin acetate:: A new antifungal agent
    McGee, WT
    Tereso, GJ
    CRITICAL CARE MEDICINE, 2003, 31 (05) : 1577 - 1578
  • [37] Acquired Flucytosine Resistance during Combination Therapy with Caspofungin and Flucytosine for Candida glabrata Cystitis
    Charlier, Caroline
    El Sissy, Carine
    Bachelier-Bassi, Sophie
    Scemla, Anne
    Quesne, Gilles
    Sitterle, Emilie
    Legendre, Christophe
    Lortholary, Olivier
    Bougnoux, Marie-Elisabeth
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2016, 60 (01) : 662 - 665
  • [38] Combination of caspofungin or anidulafungin with antimicrobial peptides results in potent synergistic killing of Candida albicans and Candida glabrata in vitro
    Harris, Mark R.
    Coote, Peter J.
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2010, 35 (04) : 347 - 356
  • [39] Mediastinal Infection With Candida glabrata in an Immunocompetent Patient
    Charaf, Christine
    Mankikar, Rohan
    Flenaugh, Eric
    Franco, Kenneth
    CHEST, 2013, 144 (04)
  • [40] Candida glabrata Mutants Demonstrating Paradoxical Reduced Caspofungin Susceptibility but Increased Micafungin Susceptibility
    Healey, Kelley R.
    Katiyar, Santosh K.
    Castanheira, Mariana
    Pfaller, Michael A.
    Edlind, Thomas D.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2011, 55 (08) : 3947 - 3949
12345